Corporate Accountability and Public Health: Sackler Ruling and Treatment Gaps in the Opioid Crisis

AJMC October 2, 2024
Giuliana Grossi

Key Takeaways

• The Supreme Court’s decision against Sackler immunity highlights a shift in corporate accountability for public health crises.
• Significant barriers exist for Medicare and Medicaid enrollees in accessing MOUD, as highlighted by the OIG report.
• The opioid crisis costs the US between $50 billion and $600 billion annually, with ongoing challenges in treatment access.
• Regional initiatives and telemedicine show promise in addressing treatment barriers, but systemic issues persist, especially for marginalized communities.

The Supreme Court’s decision, paired with the newest data demonstrating the public impact of the opioid crisis, illustrates the legal potential in addressing the crisis and the ongoing public health challenges of treatment access.

The US Supreme Court’s recent decision to strip the Sackler family...

Today's Sponsors

Today's Sponsor